IXICO PLC - Asset Resilience Ratio

Latest as of March 2014: 1.79%

IXICO PLC (IXI) has an Asset Resilience Ratio of 1.79% as of March 2014. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See IXICO PLC current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

GBX104.00K

≈ $12.65 USD Cash + Short-term Investments

Total Assets

GBX5.83 Million

≈ $708.86 USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2013)

This chart shows how IXICO PLC's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see IXICO PLC asset portfolio.

Liquid Assets Composition Over Time

This chart breaks down IXICO PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read total liabilities of IXICO PLC for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	GBX0.00	0%
Short-term Investments	GBX104.00K	1.79%
Total Liquid Assets	GBX104.00K	1.79%

Asset Resilience Insights

Limited Liquidity: IXICO PLC maintains only 1.79% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

IXICO PLC Industry Peers by Asset Resilience Ratio

Compare IXICO PLC's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	2.50%
Dianthus Therapeutics Inc. NASDAQ:DNTH	Biotechnology	63.98%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	62.24%
Damora Therapeutics, Inc. NASDAQ:DMRA	Biotechnology	0.00%
Wecome Pharmaceutical Co Ltd SHE:300878	Biotechnology	0.67%
Tectonic Therapeutic, Inc. NASDAQ:TECX	Biotechnology	86.66%
Relmada Therapeutics Inc NASDAQ:RLMD	Biotechnology	95.25%
MediWound Ltd F:M8W	Biotechnology	56.04%

Annual Asset Resilience Ratio for IXICO PLC (2000–2013)

The table below shows the annual Asset Resilience Ratio data for IXICO PLC.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2013-09-30	2.00%	GBX103.00K ≈ $12.53	GBX5.15 Million ≈ $626.97	-79.22pp
2012-09-30	81.22%	GBX8.60 Million ≈ $1.05K	GBX10.59 Million ≈ $1.29K	+3.25pp
2011-09-30	77.97%	GBX14.50 Million ≈ $1.76K	GBX18.60 Million ≈ $2.26K	-13.45pp
2010-09-30	91.42%	GBX22.50 Million ≈ $2.74K	GBX24.61 Million ≈ $2.99K	+26.66pp
2008-09-30	64.75%	GBX5.50 Million ≈ $669.19	GBX8.49 Million ≈ $1.03K	-4.60pp
2004-08-31	69.36%	GBX5.24 Million ≈ $637.19	GBX7.55 Million ≈ $918.74	-4.88pp
2003-08-31	74.23%	GBX5.13 Million ≈ $624.29	GBX6.91 Million ≈ $840.99	+2.07pp
2002-08-31	72.16%	GBX8.83 Million ≈ $1.07K	GBX12.24 Million ≈ $1.49K	-17.26pp
2001-08-31	89.42%	GBX12.67 Million ≈ $1.54K	GBX14.17 Million ≈ $1.72K	+10.12pp
2000-08-31	79.30%	GBX4.53 Million ≈ $550.80	GBX5.71 Million ≈ $694.62	--

pp = percentage points

About IXICO PLC

LSE:IXI UK Biotechnology

Market Cap

$199.82K

GBX1.64 Billion GBX

Market Cap Rank

#31336 Global

#1031 in UK

Share Price

GBX7.50

Change (1 day)

+0.00%

52-Week Range

GBX6.63 - GBX14.00

All Time High

GBX123.50